Contoura With Phorcides Compared to Wavefront Optimized LASIK

Part of paid clinical trials in Bozeman, Montana.

Sponsor
Daniel Terveen
Study ID
NCT05486546
Status
Recruiting

Conditions

  • Astigmatism
  • Myopia

Eligibility Criteria

Sex
ALL
Age
21 Years - 38 Years
Healthy Volunteers
Not accepted

Interventions

  • Contoura with Phorcides — PROCEDURE
    Participants that undergo LASIK surgery using Contoura with Phorcides Analytic Engine
  • WaveLight Wavefront Optimized — DEVICE
    Participants that undergo LASIK surgery using WaveLight Wavefront Optimized

Study Details

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Key Dates

Start date
Aug 15, 2022
Status verified
Apr 2023
Primary completion
Sep 1, 2023
Completion
Dec 1, 2023

Study Design

Enrollment
120 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Study: Phorcides
    Contoura with Phorcides used for surgical planning of LASIK procedure
  • Active Comparator: Control: Wavefront Optimized
    WaveLight Wavefront Optimized used for surgical planning of LASIK procedure

Primary Outcome Measure

Post-Op UDVA [ Time Frame: 3 months post-op ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Vance Thompson VisonBozemanMontana57105
Keeley Boever
402-740-9420
Vance Thompson VisionOmahaNebraska57105
Keeley Boever
402-740-9420
Vance Thompson VisionFargoNorth Dakota57105
Keeley Boever
402-740-9420
Vance Thompson VisionSioux FallsSouth Dakota57108
Keeley Puls
605-371-7075

Find similar trials in Bozeman, MT

Related Studies